CDKN2A and sarcoma: The fourth gene deregulated in TFCP2-rearranged sarcoma, besides ALK, CDKN2A, and MTAP, is TERT, encoding the catalytic component of the telomerase complex that protects dividing cells from progressive telomere shortening, subsequent senescence, and malignant transformation52.